We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News Medica 2024 AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Photodynamic Therapy Kills Tumors in Mice

By HospiMedica staff writers
Posted on 22 Nov 2000
A photosensitive compound (PH-10), believed to bind to cancerous tissue cells while clearing from healthy tissue, when used with laser light or low-level radiation has resulted in complete remission of tumors in 10 of 14 mice.

The study was conducted by Photogen Technologies Inc. (Knoxville, TN, USA), an emerging cancer diagnostics and therapeutics company. The findings suggest that, in general, the noninvasive targeted drug and light treatment, or photodynamic therapy, may stimulate the immune system into fighting cancer and preventing metastasis or recurrence of cancer. New tumors did not develop in mice whose cancers had been previously treated with PH-10 and laser light. Six of eight mice with renal adenocarcinoma that had PH-10 injected into tumors demonstrated complete remission as did all mice with breast cancer who had the treatment.

"We will continue to explore the possibility that tumors treated with PH-10 could work like an autologous vaccine,” said Taffy Williams, Ph.D., president and CEO of Photogen.



Related Links:
www.photogen.com

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Ultrasound Table
General 3-Section Top EA Ultrasound Table
New
Resting Electrocardiograph
ECG Top D/BT

Latest Patient Care News

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization